Saturday 17 October 2026 Export ANIK’s income statement to Excel — free account

Anika Therapeutics Inc.

ANIK Healthcare Drug Manufacturers Specialty & Generic

Anika Therapeutics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $112.8 million, down 5.91% from fiscal 2024. In the quarter to June 2026, revenue grew 15.6%, EPS grew 189.3% and free cash flow grew 61.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

19.98 0.71 −3.43%

Follow ANIK

Alert me

Market cap: $276.9M
P/E: 0.0×
Fwd P/E: −20.0×
Dividend yield: —
F-score: 6/9
Altman Z: 3.13
Beneish M: −2.84
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	1.62	1.69	1.22	1.20
P/FCF ratio Full definition →	347.01	0.00	27.77	108.60
P/Operating CF Full definition →	(285.11)	(40.49)	29.72	19.73
P/B ratio Full definition →	1.42	1.47	0.96	0.92
Price to Tangible BV Full definition →	1.53	1.58	1.03	0.99
EV/Sales Full definition →	1.51	1.55	0.93	0.91
EV/EBITDA Full definition →	354.70	0.00	0.00	0.00
EV/Operating CF Full definition →	30.38	27.84	9.41	12.61
EV/FCF Full definition →	323.14	(63.07)	21.22	82.17
Quick Ratio Full definition →	3.05	3.19	3.71	4.20
Current Ratio Full definition →	4.48	4.46	4.72	5.32
Net Debt/EBITDA Full definition →	(8.61)	10.05	(29.27)	31.69
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.65	0.63	0.57	0.54
Operating CF/Net income Full definition →	(0.21)	0.96	15.88	(2.95)
Capex/Depreciation Full definition →	(0.96)	(1.02)	(0.49)	(1.34)
Research and Development Expense of Revenue Full definition →	22.51%	22.67%	21.07%	24.97%
Selling, General and Administrative Expense of Revenue Full definition →	33.58%	60.02%	39.46%	42.68%
Intangible Assets out of Total Assets Full definition →	0.05	0.05	0.05	0.05
Share Based Compensation of Revenue Full definition →	5.62%	22.43%	8.03%	7.96%
Graham Net Nets Full definition →	0.27	0.25	0.41	0.44
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(1.78%)	(5.45%)	(7.91%)	(24.26%)
Free Cash Flow Yield Full definition →	0.29%	(1.46%)	3.60%	0.92%
Revenue per Share Full definition →	2.45	2.19	2.14	1.93
Operating CF per Share Full definition →	(0.05)	(0.36)	0.32	0.48
Capex per Share Full definition →	(0.11)	(0.11)	(0.05)	(0.13)
Free Cash Flow per Share Full definition →	(0.16)	(0.46)	0.28	0.35
Cash per Share Full definition →	2.88	3.03	4.01	4.02
Shareholders Equity per Share Full definition →	10.30	9.90	10.01	10.18
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	10.30	9.90	10.01	10.18
Free Cash Flow Full definition →	(2.13)	(6.28)	3.99	4.98
Working Capital Full definition →	77.04	72.60	81.45	82.50
Capital Expenditures Full definition →	(1.45)	(1.43)	(0.65)	(1.89)
Net Current Asset Value Full definition →	53.00	48.08	56.55	58.96
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.04	0.05	0.02	0.07
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	26.51	23.88	23.64	25.27
Average Payables Full definition →	5.50	5.81	5.83	5.77
Average Inventory Full definition →	22.74	22.09	21.30	27.96
Average Assets Full definition →	185.58	185.00	196.51	210.42
Average Common Equity Full definition →	142.48	141.15	148.73	163.33

Show all line items

Columns are period end dates

Stockrow Weekly